Figure 1.
The design of GENEr8-INH study. Part A includes patients with active inhibitors, and part B includes patients with prior inhibitors that have been tolerized. The first 4 patients received prophylactic steroids as indicated.
The design of GENEr8-INH study. Part A includes patients with active inhibitors, and part B includes patients with prior inhibitors that have been tolerized. The first 4 patients received prophylactic steroids as indicated.
